Generic Name:
lixisenatide
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, Type 2
Manufacturer:
Sanofi-aventis Canada Inc.
Call for patient/clinician input open:
Brand Name:
Adlyxine
Project Line:
Reimbursement Review
Project Number:
SR0520-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Details
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
Diabetes mellitus, Type 2
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: